220 related articles for article (PubMed ID: 33603665)
1. A Novel Alginate-Based Delivery System for the Prevention and Treatment of Pressure-Overload Induced Heart Failure.
Kumar A; Belhaj M; DiPette DJ; Potts JD
Front Pharmacol; 2020; 11():602952. PubMed ID: 33603665
[No Abstract] [Full Text] [Related]
2. Alpha-calcitonin gene-related peptide prevents pressure-overload induced heart failure: role of apoptosis and oxidative stress.
Kumar A; Supowit S; Potts JD; DiPette DJ
Physiol Rep; 2019 Nov; 7(21):e14269. PubMed ID: 31724338
[TBL] [Abstract][Full Text] [Related]
3. Alpha-calcitonin gene-related peptide is protective against pressure overload-induced heart failure.
Li J; Levick SP; DiPette DJ; Janicki JS; Supowit SC
Regul Pept; 2013 Aug; 185():20-8. PubMed ID: 23816470
[TBL] [Abstract][Full Text] [Related]
4. Alpha-Calcitonin Gene Related Peptide: New Therapeutic Strategies for the Treatment and Prevention of Cardiovascular Disease and Migraine.
Kumar A; Williamson M; Hess A; DiPette DJ; Potts JD
Front Physiol; 2022; 13():826122. PubMed ID: 35222088
[TBL] [Abstract][Full Text] [Related]
5. Experimental model of congestive heart failure induced by transverse aortic constriction in BALB/c mice.
Tannu S; Allocco J; Yarde M; Wong P; Ma X
J Pharmacol Toxicol Methods; 2020; 106():106935. PubMed ID: 33096237
[TBL] [Abstract][Full Text] [Related]
6. Genetic ablation of TRPV1 exacerbates pressure overload-induced cardiac hypertrophy.
Zhong B; Rubinstein J; Ma S; Wang DH
Biomed Pharmacother; 2018 Mar; 99():261-270. PubMed ID: 29334670
[TBL] [Abstract][Full Text] [Related]
7. Differential mRNA Expression and Circular RNA-Based Competitive Endogenous RNA Networks in the Three Stages of Heart Failure in Transverse Aortic Constriction Mice.
Li X; Tan W; Zheng S; Pyle WG; Zhu C; Chen H; Kang L; Wu J; Zou Y; Backx PH; Yang FH
Front Physiol; 2022; 13():777284. PubMed ID: 35330931
[TBL] [Abstract][Full Text] [Related]
8. Cytosolic DNA sensor cGAS plays an essential pathogenetic role in pressure overload-induced heart failure.
Hu D; Cui YX; Wu MY; Li L; Su LN; Lian Z; Chen H
Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1525-H1537. PubMed ID: 32383996
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of resveratrol against pressure overload-induced heart failure.
Gupta PK; DiPette DJ; Supowit SC
Food Sci Nutr; 2014 May; 2(3):218-29. PubMed ID: 24936291
[TBL] [Abstract][Full Text] [Related]
10. Variable phenotype in murine transverse aortic constriction.
Mohammed SF; Storlie JR; Oehler EA; Bowen LA; Korinek J; Lam CS; Simari RD; Burnett JC; Redfield MM
Cardiovasc Pathol; 2012; 21(3):188-98. PubMed ID: 21764606
[TBL] [Abstract][Full Text] [Related]
11. Exogenous Cardiac Bridging Integrator 1 Benefits Mouse Hearts With Pre-existing Pressure Overload-Induced Heart Failure.
Li J; Agvanian S; Zhou K; Shaw RM; Hong T
Front Physiol; 2020; 11():708. PubMed ID: 32670093
[No Abstract] [Full Text] [Related]
12. [The Observation of Liver and Kidney Injury and the Activation of Macrophages in the Overload Pressure Induced Cardiac Hypertrophy/Heart Failure Mouse Model].
Quan Y; Tian GE; Zhou JT; Wu WC; Liu XJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):331-336. PubMed ID: 32543138
[TBL] [Abstract][Full Text] [Related]
13. A time-series minimally invasive transverse aortic constriction mouse model for pressure overload-induced cardiac remodeling and heart failure.
Wang X; Zhu X; Shi L; Wang J; Xu Q; Yu B; Qu A
Front Cardiovasc Med; 2023; 10():1110032. PubMed ID: 36891245
[TBL] [Abstract][Full Text] [Related]
14. A Novel α-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure.
Aubdool AA; Thakore P; Argunhan F; Smillie SJ; Schnelle M; Srivastava S; Alawi KM; Wilde E; Mitchell J; Farrell-Dillon K; Richards DA; Maltese G; Siow RC; Nandi M; Clark JE; Shah AM; Sams A; Brain SD
Circulation; 2017 Jul; 136(4):367-383. PubMed ID: 28446517
[TBL] [Abstract][Full Text] [Related]
15. Ablation of cardiac TIGAR preserves myocardial energetics and cardiac function in the pressure overload heart failure model.
Okawa Y; Hoshino A; Ariyoshi M; Kaimoto S; Tateishi S; Ono K; Uchihashi M; Iwai-Kanai E; Matoba S
Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1366-H1377. PubMed ID: 30901275
[TBL] [Abstract][Full Text] [Related]
16. Ca
Baier MJ; Klatt S; Hammer KP; Maier LS; Rokita AG
J Mol Cell Cardiol; 2020 Jan; 138():212-221. PubMed ID: 31836540
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective Effects of QiShenYiQi Dripping Pills on Transverse Aortic Constriction-Induced Heart Failure in Mice.
Ruan G; Ren H; Zhang C; Zhu X; Xu C; Wang L
Front Physiol; 2018; 9():324. PubMed ID: 29666587
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of recombinant human erythropoietin against pressure overload-induced left ventricular remodeling and premature death in mice.
Wang W; Kagaya Y; Asaumi Y; Fukui S; Takeda M; Shimokawa H
Tohoku J Exp Med; 2011 Oct; 225(2):131-43. PubMed ID: 21937860
[TBL] [Abstract][Full Text] [Related]
19. BMP7-based peptide agonists of BMPR1A protect the left ventricle against pathological remodeling induced by pressure overload.
Salido-Medina AB; Gil A; Expósito V; Martínez F; Redondo JM; Hurlé MA; Nistal JF; García R
Biomed Pharmacother; 2022 May; 149():112910. PubMed ID: 35616049
[TBL] [Abstract][Full Text] [Related]
20. Chemogenetic activation of intracardiac cholinergic neurons improves cardiac function in pressure overload-induced heart failure.
Dyavanapalli J; Hora AJ; Escobar JB; Schloen J; Dwyer MK; Rodriguez J; Spurney CF; Kay MW; Mendelowitz D
Am J Physiol Heart Circ Physiol; 2020 Jul; 319(1):H3-H12. PubMed ID: 32412778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
